a public good project by the
Synthesis
Company
of California

© 2026

Chiara Milanesi | doi.page

0 works0 citations0 h-index

Chiara Milanesi

Sardegna Ricerche (Italy)(IT)Sacmi (Italy)(IT)IRCCS Humanitas Research Hospital(IT)

Publications by Year

Research Areas

Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Kruppel-like factors research, Photodynamic Therapy Research Studies

Most-Cited Works

→ Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms(2013)1,952 cited
→ JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes(2013)576 cited
→ Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis(2014)381 cited
→ Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms(2015)280 cited
→ Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms(2015)272 cited
→ Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation(2016)252 cited

→ Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms(2013)92 cited

→ Hemopoiesis in crustacea decapoda: origin and evolution of hemocytes and cyanocytes of Carcinus maenas(1977)80 cited

→ Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System(2017)72 cited

→ CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis(2014)71 cited